Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RAMIPRIL vs RANOLAZINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RAMIPRIL vs RANOLAZINE: Safety Overview

Metric RAMIPRIL RANOLAZINE
Total FAERS Reports 33,063 9,522
Deaths Reported 3,786 1,048
Death Rate 11.5% 11.0%
Hospitalizations 17,747 3,367
Average Patient Age 65.4 yrs 70.4 yrs
% Female Patients 53.1% 42.0%
FDA Approval Date Apr 15, 2014 Apr 15, 2025
Manufacturer GSMS, Incorporated AvKARE
Route ORAL ORAL
Marketing Status Discontinued Discontinued